An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study
Phase III
Infectious Disease, Gastroenterology, Hepatitis C
Pre-screening
A Phase 3 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy in Participants with Chronic HDV Infection (ECLIPSE 1)
Phase III
Infectious Disease, Gastroenterology, Hepatitis D
Pre-screening
A Phase 2b Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Tobevibart+Elebsiran Combination Therapy versus Bulevirtide in Participants with Chronic HDV Infection (ECLIPSE 3)
Phase IIb
Infectious Disease, Gastroenterology, Hepatitis D
Pre-screening
A Phase 3, Randomized, Comparator-Controlled, Double-Blind, Multicenter Study to Evaluate the Immunogenicity, Safety and Lot to Lot Consistency of Three Lots of a PIKA Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried in Healthy Adults using a Post-Exposure Prophylaxis schedule
Phase III
Infectious Disease, Vaccination
Follow-up
A Phase 3, Randomized, Observer-Blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of a High dose MF59-Adjuvanted Quadrivalent Subunit Cell-derived Influenza Vaccine (aQIVc HD) in Comparison with a nonadjuvanted Quadrivalent Recombinant Influenza Vaccine (QIVr) and an MF59 Adjuvanted Quadrivalent Subunit Egg-derived Influenza Vaccine (aQIV), in Adults Aged 50 Years and Older.
Phase III
Infectious Disease, Pulmonology, Vaccination
Completed
A Multi-center, Randomized, Blinded, Placebo controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine as Booster in Participants Aged 18 Years and Older who Completed Primary/1 Booster Dose(s) of SARS-CoV-2 Vaccination
Phase III
Infectious Disease, Pulmonology, Vaccination
Completed
A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT06 Compared with EU-Eylea® in Subjects with Neovascular (wet) Age-related Macular Degeneration
Phase III
Ophthalmology
Completed
A Phase 3, multicenter, randomized, double-blind, 24-week study of the clinical and antiviral effect of S-217622 compared with placebo in non-hospitalized participants with COVID-19
Phase III
Infectious Disease, Pulmonology, Therapeutic
Completed
A Phase 3, Randomized, Observer-blind, Multicenter Study to Evaluate the Efficacy, Immunogenicity and Safety of Seqirus' Cell-Based Quadrivalent Subunit Influenza Virus Vaccine (QIVc) Compared to a Non-Influenza Vaccine When Administrated in Healthy Subjects Aged 6 Months Through 47 Months
Phase III
Infectious Disease, Pediatrics, Vaccination
Completed
A Global, Multi-center, Randomized, Double-Blind, Placebo Controlled, Phase 3 Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Sequential Immunization of Recombinant SARS CoV-2 Fusion Protein Vaccine (V-01) Against COVID-19 in Healthy Adults Aged 18 Years and Older after the Vaccination of 2 Doses of Inactivated Vaccines
Phase III
Infectious Disease, Pulmonology, Vaccination
Completed
A Phase-III Randomized, Double Blind, Placebo controlled Clinical Trial in 18 Years of Age and Above to Determine the Safety and Efficacy of ZF2001, a Recombinant Novel Coronavirus Vaccine (CHO cell) for Prevention of COVID-19
Phase III
Infectious Disease, Pulmonology, Vaccination
Completed